Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manali A Bhave

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Oncology Reports|March 3, 2017
Extended Endocrine Therapy: Is 5 Years Enough?Manali A Bhave, N Lynn Henry
Clinical Breast Cancer|November 4, 2022
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical CenterJeffrey Aldrich, Princess Ekpo, Manali Rupji, et al.
Annals of Surgical Oncology|July 26, 2019
Is Routine Recurrence Score Testing in Patients Older than 70 Years of Age Warranted? An Evaluation of the National Cancer Database After TAILORxRachel M Lee, Jeffrey M Switchenko, Tran B Ho, et al.
Clinical Breast Cancer|January 24, 2018
Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast CancerManali A Bhave, Kelly A Speth, Kelley M Kidwell, et al.
Oncotarget|May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancerRubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.
Breast Cancer Research and Treatment|June 13, 2024
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practiceManali A Bhave, Julia C F Quintanilha, Hanna Tukachinsky, et al.
Clinical Nuclear Medicine|February 2, 2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response AssessmentOmotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Oncology Reports|March 3, 2017
Extended Endocrine Therapy: Is 5 Years Enough?Manali A Bhave, N Lynn Henry
Clinical Breast Cancer|November 4, 2022
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical CenterJeffrey Aldrich, Princess Ekpo, Manali Rupji, et al.
Annals of Surgical Oncology|July 26, 2019
Is Routine Recurrence Score Testing in Patients Older than 70 Years of Age Warranted? An Evaluation of the National Cancer Database After TAILORxRachel M Lee, Jeffrey M Switchenko, Tran B Ho, et al.
Clinical Breast Cancer|January 24, 2018
Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast CancerManali A Bhave, Kelly A Speth, Kelley M Kidwell, et al.
Oncotarget|May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancerRubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.
Breast Cancer Research and Treatment|June 13, 2024
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practiceManali A Bhave, Julia C F Quintanilha, Hanna Tukachinsky, et al.
Clinical Nuclear Medicine|February 2, 2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response AssessmentOmotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, et al.
Pageof 1